1Eskişehir Public Health Management, Eskişehir, Turkey - 2Yeni Family Health Care Center, Eskişehir, Turkey - 3Department of Public Health, Yildirim Beyazit University, Turkey


Purpose: Our aim is to evaluate the hepatitis B surface antigen (HBsAg), hepatitis B surface antibody (AntiHBs) and AntiHCV negativity and positivity rates which can be investigated in the primary care in Type 2 Diabetes Mellitus (DM) patients in this study.

Material and method: The recordings of patients who were diagnosed with type 2 diabetes and whose hepatitis serology was recorded in Eskisehir Tepebaşı District Yeni Family Health Center’s information management system program between the dates of 01.01.2016 - 31.12.2016 were evaluated retrospectively. Age, gender, comorbid diseases of patients were noted. Hepatitis serology and routine blood test results in the last 3 months were taken from the database. SPSS 21 program was used for statistical analyze.

Results: A total of 300 patients were reached. 182 (60.7%) of the patients were female and 118 (39.3%) were male. The mean age of the patients was 58.66 ± 11.44 years. When the patients were questioned regarding treatment method of diabetes, it was found out that 205 patients (68.3%) received only oral antidiabetic (OAD), 54 patients (18.0%) received insulin with OAD, and 41 patients (13.7%) received only insulin therapy. Of the 300 patients in the study group, 16 (5.3%) were hepatitis B surface antigen (HBsAg) positive, 62 (20.7%) were hepatitis B surface antibody (AntiHBs) positive and 7 (2.3%) were AntiHCV positive.

Conclusion: Vaccination rates of patients can be increased by spending more time on counseling about vaccination and by emphasizing possible problems they may face if not vaccinated.


Type 2 DM, Hepatitis B, Hepatitis C